CONTRACTAPPROVED

Mississippi Division of Medicaid Awards License Contract to LIFYORLI (August 2026)

Mississippi Division of Medicaid
Approved
Aug 11, 2026

The 30-second brief

What it covers

The committee approved MedImpact's recommendation to make Lifyorli non-preferred in the oncology formulary class. The change is scheduled to take effect October 1, 2026.

Who holds it

LIFYORLI holds this license contract with Mississippi Division of Medicaid.

Hear about the next contract at Mississippi Division of Medicaid early.

Get pre-RFP alerts free

Free account · 30-second setup · No credit card

Contract details

Contract type
License
Document date
August 11, 2026
Vendor
LIFYORLI
Source document
Mississippi Division of Medicaid Minutes Pharmacy & Therapeutics Committee Meeting 2026-08-11 (Minutes)

More Mississippi Division of Medicaid contracts

Questions about this contract

Who was awarded the license contract by Mississippi Division of Medicaid?

LIFYORLI was awarded this license contract by Mississippi Division of Medicaid, as recorded on August 11, 2026.

What type of contract is this?

This is a License contract, documented as a minutes record.

Where was this contract approved?

This contract appears in Mississippi Division of Medicaid Minutes Pharmacy & Therapeutics Committee Meeting 2026-08-11 (Minutes), dated August 11, 2026 from Mississippi Division of Medicaid. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What is Mississippi Division of Medicaid currently buying?

Explore Mississippi Division of Medicaid's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

Work in government? Get Civic IQ free →